Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
This was a 1-week study of desloratadine (DL) plus oxybutynin (OXY) at two dose levels in the
treatment of post-nasal drip in participants with seasonal allergic rhinitis. Participants
received either desloratadine twice a day, oxybutynin twice a day, desloratadine plus
lower-dose oxybutynin twice a day, desloratadine plus higher-dose oxybutynin twice a day, or
placebo for 7 days.